Price loading...

The 2023-2028 Outlook for Bone Marrow Autologous Cell Therapies in China

Price data last checked 92 day(s) ago - refreshing...

View at Amazon

Price History & Forecast

No Price Data Available

Price history will appear here once data is collected from Amazon.

Price Distribution

No price data available for histogram

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
16 August 2022
Listed Since
24 August 2022

Similar Products You Might Like

The 2023-2028 Outlook for Bone Marrow Transplants in China
98% match

The 2023-2028 Outlook for Bone Marrow Transplants in China

£495.00 29 Jan 2026
The 2023-2028 World Outlook for Bone Marrow Autologous Cell Therapies
97% match

The 2023-2028 World Outlook for Bone Marrow Autologous Cell Therapies

Out of Stock 25 Jan 2026
The 2023-2028 Outlook for Multiple Myeloma Treatments in China
97% match

The 2023-2028 Outlook for Multiple Myeloma Treatments in China

£495.00 25 Jan 2026
The 2023-2028 Outlook for Cell Culture in Healthcare in China
96% match

The 2023-2028 Outlook for Cell Culture in Healthcare in China

£495.00 25 Jan 2026
The 2023-2028 Outlook for Bone Marrow Autologous Cell Therapies in the United States
96% match

The 2023-2028 Outlook for Bone Marrow Autologous Cell Therapies in the United States

£520.00 24 Jan 2026
The 2023-2028 Outlook for Bone Growth Stimulators in China
96% match

The 2023-2028 Outlook for Bone Growth Stimulators in China

£495.00 13 Dec 2025
The 2023-2028 Outlook for Natural Killer Cell Therapeutics in China
96% match

The 2023-2028 Outlook for Natural Killer Cell Therapeutics in China

£495.00 12 Jan 2026
The 2023-2028 Outlook for Immunology Therapeutics in China
96% match

The 2023-2028 Outlook for Immunology Therapeutics in China

£495.00 12 Jan 2026
The 2023-2028 Outlook for Lymphoma Treatments in China
96% match

The 2023-2028 Outlook for Lymphoma Treatments in China

£495.00 23 Jan 2026
The 2023-2028 Outlook for Oncolytic Virus Immunotherapies in China
96% match

The 2023-2028 Outlook for Oncolytic Virus Immunotherapies in China

£495.00 11 Jan 2026
The 2023-2028 Outlook for Erythropoietin Drugs in China
96% match

The 2023-2028 Outlook for Erythropoietin Drugs in China

£495.00 01 Feb 2026
The 2023-2028 Outlook for Bone Marrow Autologous Cell Therapies in India
96% match

The 2023-2028 Outlook for Bone Marrow Autologous Cell Therapies in India

£515.00 21 Jan 2026
The 2023-2028 Outlook for Non-Hodgkin Lymphoma Treatments in China
96% match

The 2023-2028 Outlook for Non-Hodgkin Lymphoma Treatments in China

£495.00 12 Jan 2026
The 2023-2028 Outlook for Myeloproliferative Disorder Drugs in China
96% match

The 2023-2028 Outlook for Myeloproliferative Disorder Drugs in China

£495.00 26 Jan 2026
The 2023-2028 Outlook for Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatments in China
96% match

The 2023-2028 Outlook for Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatments in China

£495.00 24 Jan 2026
The 2023-2028 Outlook for Sarcopenia Treatments in China
96% match

The 2023-2028 Outlook for Sarcopenia Treatments in China

£495.00 25 Feb 2026
The 2023-2028 Outlook for Basal Cell Carcinoma Treatments in China
96% match

The 2023-2028 Outlook for Basal Cell Carcinoma Treatments in China

£495.00 08 Jan 2026
The 2023-2028 Outlook for Chemotherapy and Antibody Combination Antibody Therapies in China
96% match

The 2023-2028 Outlook for Chemotherapy and Antibody Combination Antibody Therapies in China

£495.00 07 Jan 2026
The 2023-2028 Outlook for Genetic Modification Therapies in China
96% match

The 2023-2028 Outlook for Genetic Modification Therapies in China

£495.00 09 Jan 2026
The 2023-2028 Outlook for Non-Hodgkin Lymphoma in China
96% match

The 2023-2028 Outlook for Non-Hodgkin Lymphoma in China

£495.00 19 Apr 2026
The 2023-2028 Outlook for Uterine Cancer Therapeutics and Diagnostics in China
96% match

The 2023-2028 Outlook for Uterine Cancer Therapeutics and Diagnostics in China

£495.00 20 Mar 2026
The 2023-2028 Outlook for Metabolomics Products in China
96% match

The 2023-2028 Outlook for Metabolomics Products in China

£495.00 19 Apr 2026
The 2023-2028 Outlook for Iron Deficiency Anemia Therapies in China
96% match

The 2023-2028 Outlook for Iron Deficiency Anemia Therapies in China

£495.00 29 Jan 2026
The 2023-2028 Outlook for Guillain-Barre Syndrome Therapeutics in China
96% match

The 2023-2028 Outlook for Guillain-Barre Syndrome Therapeutics in China

£495.00 20 Mar 2026